In an effort to reduce the mortality and morbidity by snakebite envenomation, the health authorities of Mali have started using our antivenom. The production of antivenom is complex and due to increasing demand, measures have been taken to increase the number of vials available per year. This effort aims to prevent the well-known shortages of this vital antivenom. In working… Read more →
Where and how is the antivenom EchiTAb-Plus-ICP produced in Costa Rica
The supply to MSF is for their humanitarian work in this country.
EchiTAb-Plus-ICP has been well received in Burkina Faso, where it has been used effectively against the most common venomous snakes, such as the West African Carpet Viper, the Puff Adder and the Blacked-Necked Spitting Cobra.
The highest incidence of snakebite in Africa occurs in the West African savanna region. In this region, saw-scaled or carpet vipers (E. ocellatus, E. leucogaster, E. jogeri), spitting cobras (Naja nigricollis and N. katiensis) and puff adders (Bitis arietans) are common causes of serious envenoming. Throughout eastern and southern Africa, the puff adder is thought to be responsible for most… Read more →
This is the country were clinical trials took place and we are happy to say, the use of our antivenom has been spreading and it has proved vital in the fight of this neglected tropical disease in Nigeria.
